The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

被引：0
|
作者：
Sollelis, E. [1 ,2 ,3 ]
Quinard, R. Minet [4 ]
Bouguen, G. [5 ]
Goutte, M. [1 ,2 ,3 ]
Goutorbe, F. [1 ,6 ]
Bouvier, D. [4 ]
Pereira, B. [7 ]
Bommelaer, G. [1 ,2 ,3 ]
Buisson, A. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Estaing, Gastroenterol Dept, Clermont Ferrand, France
[2] Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France
[3] USC INRA 2018, Microbes Intestine Inflammat & Susceptibil Host, Clermont Ferrand, France
[4] Univ Hosp G Montpied, Biochem Lab, Clermont Ferrand, France
[5] Univ Hosp, Rennes, France
[6] Hosp Bayonne, Gastroenterol Dept, Bayonne, France
[7] Univ Hosp, Biostat Unit, DRCI Clermont Ferrand, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P504
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [11] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
  • [12] Deep Remission in Crohn's Disease Does Not Prevent Disease Relapse After Withdrawal of Anti-TNFα Therapy
    Duricova, Dana
    Bortlik, Martin
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Lukas, Milan
    GASTROENTEROLOGY, 2015, 148 (04) : S61 - S61
  • [13] Faecal calprotectin as therapeutic target in patients with Crohn's disease treated with anti-TNF: a meta-analysis of individual data
    Mami, A.
    Nancey, S.
    Pugliese, D.
    Molander, P.
    Boschetti, G.
    Nogueira, I.
    Pereira, B.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S205 - S206
  • [14] FAECAL CALPROTECTIN AS THERAPEUTIC TARGET IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF: A META-ANALYSIS OF INDIVIDUAL DATA
    Mami, Alia
    Nancey, Stephane
    Pugliese, Daniela
    Molander, Pauliina
    Boschetti, Gilles
    Nogueira, Islaine
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S708 - S708
  • [15] Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn's disease
    Pavlidis, P.
    Chung-Faye, G.
    Dubois, P.
    Bjarnason, I.
    Hayee, B. H.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S338 - S338
  • [16] RADIOLOGIC PREDICTORS OF SHORT-TERM CLINICAL REMISSION IN PATIENTS WITH PERIANAL CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY
    Parlow, Simon
    Macdonald, Blair
    Abdul-Kareem, Ihssan
    Rhee, Gaeun
    Sabri, Elham
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (06) : S186 - S187
  • [17] Adequate Trough Concentrations and Sustained TNF Suppression Early on During Induction Therapy With Adalimumab Predict Remission in Anti-TNF Naive Crohn's Disease Patients
    Vande Casteele, Niels
    Mould, Diane R.
    Gils, Ann
    Tops, Sophie
    Van den Broeck, Karolien
    Ballet, Vera
    Ferrante, Marc
    Van Assche, Gert A.
    Vermeire, Severine
    Baert, Filip J.
    GASTROENTEROLOGY, 2015, 148 (04) : S854 - S855
  • [18] Natalizumab induces sustained response and remission in the absence of concomitant immunosuppressants in patients with Crohn's disease who failed prior Anti-TNFα therapy
    Lashner, B.
    Colombel, J. F.
    Enns, R.
    Feagan, B. G.
    Fedorak, R. N.
    Hanauer, S. B.
    Lawrance, I. C.
    Panaccione, R.
    Present, D.
    Ridgeerts, P.
    Sandborn, W. J.
    Sanders, M.
    Schreiber, S.
    Spehlmann, M. E.
    Talassay, Z.
    van Deventer, S.
    Volfova, M.
    Wolf, D. C.
    Targan, S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S493 - S493
  • [19] Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    del Carmen R-Grau, Maria
    Chaparro, Maria
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    Castro, Luisa
    Castro, Manuel
    Domenech, Eugeni
    Mancenido, Noemi
    Lazaro Perez-Calle, Jose
    Taxonera, Carlos
    Barrio, Jesus
    De Francisco, Ruth
    Fernandez-Salgado, Estela
    Luzon, Lara
    Merino, Olga
    Oltra, Lorena
    Saro, Cristina
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Ginard, Daniel
    Gutierrez, Ana
    Vera, Isabel
    Anton, Rosario
    Ber, Yolanda
    Calvet, Xavier
    Gisbert, Javier P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 613 - 619
  • [20] Oesophagal involvement is a predictor of anti-TNF treatment failure in patients with Crohn's disease
    Sakata, Y.
    Tsuruoka, N.
    Esaki, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S254 - S254
12345